Bionano: Transforming the Way the World Sees the Genome (original) (raw)
Our OGM systems, software solutions and uncompromising support allow you to reveal more genomic variation that matters across a variety of applications in clinical care, research and therapeutics.
Oncology
Solve the complex biology of hematological malignancies and solid tumors by revealing structural variants traditional methods miss and create new opportunities for personalized care.
Genetic Disease
See chromosomal aberrations with digital clarity and deliver new answers for reproductive health issues, neurodevelopmental delay and rare disease.
Cell Bioprocessing
Enhance your quality control and ensure the genomic integrity and stability of cell lines for producer cell lines, research cell lines and cell therapy applications.
Cytogenomics
Transform your laboratory workflow and detect all classes of chromosomal aberrations in cancer and genetic disease cases with digital precision.
Molecular Genomics
Achieve more comprehensive structural variant profiles than sequencing alone provides and maximize pathogenic findings in your cancer and genetic disease cases.
Make An Impact
Join the growing community of Bionano users worldwide who are moving healthcare and hope forward with our solutions. Watch their stories and learn how Bionano OGM systems and software solutions can help you break through.
FEATURED STORIES
OGM Makes A Huge Impact On Clinical Research
Sign up to watch this webinar and hear how OGM makes a huge impact on clinical research, as Dr. Rashmi Kanagal-Shamanna and Dr. Guillermo Garcia-Manero (MD Anderson Cancer Center) discuss OGM for Enhanced Characterization of Myelodysplastic Syndromes.
FEATURED STORIES
Dr. Wallace’s Breakthrough
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore.
Learn More
Our Products
Stratys™ System
Reveal all classes of structural variants and leave the limits of traditional cytogenetics and sequencing behind with OGM and the Stratys System.
Saphyr® System
The Saphyr system provides genome-wide detection and analysis of all classes of structural variants from ultra-high molecular weight DNA using OGM.
Analysis Software
Bionano's VIA is the only analysis software that receives and interprets data from optical genome mapping (OGM), next-generation sequencing (NGS) and microarrays to contextualize all classes of genomic variation and drive meaningful insights.
Ionic® Purification System
The Ionic system uses isotachophoresis (ITP) to isolate, purify, and concentrate genomic DNA and RNA from cells, tissue, and FFPE samples with Ionic G2 chemistry. DNA and RNA samples prepared by the system require just a few minutes of hands-on time per sample.
Events
CGC 2024
August 4 - 7, 2024
The CGC Annual Meeting is a unique gathering aimed at bringing the clinical genomics community together to create an environment of collaboration, education and networking.
ISSCR 2024
July 10 - 13, 2024
International Society for Stem Cell Research (ISSCR) conference is the world’s best and brightest in stem cell research and regenerative medicine are coming together, with more than 4,000 scientists from around the globe.
ESHG 2024
June 1 - 4, 2024
The European Society of Human Genetics annual conference is the major scientific and professional event in human genetics which brings together European and international geneticists.
NEWS
BLOG
09/07/2024
Unlocking the Mysteries of Rare Diseases with Optical Genome Mapping: Insights from ESHG 2024
BLOG
25/06/2024
Exploring the Latest Insights in Prenatal Cytogenomic Assessment: A Review by Leading Experts
[Learn More](http://Exploring the Latest Insights in Prenatal Cytogenomic Assessment: A Review by Leading Experts)
PRESS RELEASE
20/06/2024
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
PRESS RELEASE
21/05/2024
Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy
PRESS RELEASE
24/04/2024
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing
PRESS RELEASE
17/04/2024
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence.
BLOG
15/04/2024
Dr. Jeanne Loring shares her groundbreaking research in iPSCs and its impactful influence in the field of cell and gene therapy and how OGM has redefined safety considerations in cell characterization.
Explore Opportunities.
Join a dynamic environment and take on work that makes a meaningful impact.
